AmerisourceBergen Names Terrance P. Haas President of AmerisourceBergen Drug Corporation
VALLEY FORGE, Pa.--(BUSINESS WIRE)--Feb. 16, 2004--AmerisourceBergen Corporation (NYSE:ABC), the largest pharmaceutical services company in the U.S. dedicated solely to the pharmaceutical supply channel, today announced the promotion, effective immediately, of Terrance (Terry) P. Haas, 38, to the new position of Corporate Senior Vice President and President of AmerisourceBergen Drug Corporation, the Company's wholly owned pharmaceutical distribution subsidiary. In his new role, Mr. Haas will be responsible for the Drug Corporation's regional pharmaceutical distribution operations, procurement activities, sales and marketing, and the building of the Company's new distribution network under the "Optimiz" program. For the last year, as Senior Vice President, Operations, Mr. Haas headed regional pharmaceutical distribution operations and the Optimiz program for the Company. He will report to Kurt J. Hilzinger, President and Chief Operating Officer of AmerisourceBergen.
"Terry's new role will facilitate AmerisourceBergen's ability to expand its pharmaceutical distribution business and develop new, integrated business solutions for healthcare providers and pharmaceutical manufacturers," said R. David Yost, AmerisourceBergen Chief Executive Officer. "He is an outstanding executive who brings a broad and in-depth knowledge of the pharmaceutical services business to his new position."
Mr. Hilzinger said, "Growing the business by focusing our expanding capability on the needs of our provider and manufacturing customers will be a major focus of Terry's new responsibilities. His operational experience, organizational capability and proven leadership make him uniquely qualified for this important role."
The AmerisourceBergen Specialty, Packaging and Technology groups, as well as PharMerica and Corporate Information Resources, will continue to report to Mr. Hilzinger.
Prior to heading the Company's distribution operations, Mr. Haas was Senior Vice President, Strategic Integration where he successfully led the planning and execution of the integration of AmeriSource Health Corporation and Bergen Brunswig Corporation following their merger in August 2001.
Before the merger, he directed corporate operations and procurement as Senior Vice President, Supply Chain Management for AmeriSource Health. Prior to that role, he held numerous management positions with AmeriSource over a nearly 20-year career at the company or its predecessors, including Vice President of Strategic Integration, Regional Vice President of the South Central Region and General Manager of the Paducah distribution center.
He earned a Bachelor of Science degree from St. Louis University, majoring in business administration with concentrations in finance and marketing, and a Master of Business Administration degree from the University of Notre Dame.
AmerisourceBergen (NYSE:ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply channel. It is the leading distributor of pharmaceutical products and services to the hospital market, physician's offices, alternate care and mail order facilities, and independent and chain pharmacies. The Company is also a leader in the long term care pharmacy marketplace, the workers' compensation fulfillment business and contract packaging for manufacturers. With more than $45 billion in annualized operating revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 14,000 people. AmerisourceBergen is ranked #24 on the Fortune 500 list and was ranked #6 in the 2003 Business Week 50, a list of the 50 best performing companies in the S & P 500. For more information, go to www.amerisourcebergen.com.
This news release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. Forward-looking statements may include statements addressing future financial and operating results of AmerisourceBergen and the benefits and other aspects of the 2001 merger between AmeriSource Health Corporation and Bergen Brunswig Corporation.
The following factors, among others, could cause actual results to differ materially from those described in any forward-looking statements: competitive pressures; the loss of one or more key customer relationships; customer insolvencies; changes in customer mix; changes in pharmaceutical manufacturers' pricing and distribution policies; regulatory changes; changes in U.S. government policies; failure to integrate the businesses of AmeriSource and Bergen Brunswig successfully; failure to obtain and retain expected synergies from the merger of AmeriSource and Bergen Brunswig; and other economic, business, competitive, regulatory and/or operational factors affecting the business of AmerisourceBergen generally.
More detailed information about these factors is set forth in AmerisourceBergen's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for fiscal 2003.
AmerisourceBergen is under no obligation to (and expressly disclaims any such obligation to) update or alter any forward looking statements whether as a result of new information, future events or otherwise.
CONTACT: AmerisourceBergen Corporation, Valley Forge Michael N. Kilpatric, 610-727-7118 email@example.com SOURCE: AmerisourceBergen Corporation